Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Pigs ‘could be a better model for human influenza’
The results suggest that targeting the lower respiratory tract with aerosol vaccination could be more effective in preventing severe disease.

’Striking difference’ to the same vaccine in pigs and ferrets 

A new study has raised questions about whether ferrets are a good model for studying human influenza.

Ferrets are considered to be a gold standard animal model for influenza research, but scientists now say that S-FLU - a universal flu vaccine candidate - evokes different immune responses in pigs and ferrets.

Findings published in the Journal of Immunology suggest that pigs may offer a more faithful representation of influenza disease in humans.

S-FLU is a weakened strain of flu virus, designed to trigger a response from T cells that are able to react to multiple strains of flu.

Researchers found a ‘striking difference’ in the way that pigs and ferrets responded to the same vaccine. When administered to pigs, the vaccine activated a newly-identified type of T cell, against a flu virus of a different strain. Disease severity was reduced, but the amount of virus stayed the same.

When it was administered to ferrets, however, the viral replication was reduced, as was the amount of virus transmitted to other animals. Scientists said pigs provide a model that is closer in size and has a very similar respiratory system to humans. Pigs are also naturally infected with influenza viruses.

The team’s discovery of a new type of T cell - tissue-resident memory T-cells - also sheds light on how influenza is fought in the lung.

The results also suggest that targeting the lower respiratory tract with aerosol vaccination could be more effective in preventing severe disease in pigs. This finding offers promising evidence that the same could be true in humans.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.